author-photo

Takeshi Suto

44

Papers

255

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Clinicopathological Characteristics of Low-Grade Appendiceal Mucinous Neoplasm.

2021 Digestive Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Clinical Significance of Lymph Node Dissection and Lymph Node Metastasis in Primary Appendiceal Tumor Patients After Curative Resection: a Retrospective Multicenter Cohort Study.

2021 Journal of Gastrointestinal Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.

2020 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

2020 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Clinical impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) treated with regorafenib or trifluridine/tipiracil as later-line.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum

2019 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study

2019 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Predictive factors for early mortality after initiation of regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)